Literature DB >> 5796358

Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man.

A Silvers, R S Swenson, J W Farquhar, G M Reaven.   

Abstract

Insulin-(131)I was administered intravenously to normal subjects, to patients with maturity-onset diabetes and normal renal function, and to nondiabetic patients with renal failure. The ensuing plasma disappearance curves of immunoprecipitable radioactive insulin were determined, and these data were analyzed in a variety of ways. Firstly, fractional irreversible loss rates of insulin from plasma were calculated and found to be greatly diminished in patients with renal failure (t((1/2)) = 39 min), as compared with normal (t((1/2)) = 15 min) and diabetic subjects (t((1/2)) = 12 min). Secondly, plasma insulin-(131)I disappearance curves were resolved into sums of three exponentials by the method of "peeling," and values for the resultant three slopes and half-lives were determined. Patients with normal renal function had similar values for all parameters, while those patients with renal failure were differentiated on the basis of the slope of the last component, with a prolongation of its half-life to 275 min (approximately twice normal). Finally, a three pool model was formulated to describe the kinetics of plasma insulin disappearance in man, representing plasma (pool 1), interstitial fluid (pool 2), and all tissues in which insulin is utilized and degraded (pool 3). The proposed model adequately describing the disappearance curves of insulin-(131)I observed in all patients indicated that volumes (per cent body weight) of pool 1 (4.04) and pool 2 (10.11), calculated on the basis of the model and the experimental data, corresponded closely to estimates of plasma and interstitial fluid volumes obtained by independent means. It also demonstrated that patients with renal failure were characterized by a decreased removal rate of insulin from pool 3 and an increased recycling rate of insulin from pool 3 to pool 2. It is concluded that the proposed model represents a reasonable description of the kinetics of insulin distribution and degradation, and that its use provides quantitative insights into the physiology of insulin metabolism.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5796358      PMCID: PMC322373          DOI: 10.1172/JCI106112

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Complete solution of the three-compartment model in steady state after single injection of radioactive tracer.

Authors:  S M SKINNER; R E CLARK; N BAKER; R A SHIPLEY
Journal:  Am J Physiol       Date:  1959-02

2.  A comparison of the behavior of insulin and insulin labeled with I 131 in serum.

Authors:  G W SCOTT; T E PROUT; J A WEAVER; S P ASPER
Journal:  Diabetes       Date:  1958 Jan-Feb       Impact factor: 9.461

3.  Inulin space and total exchangeable sodium in patients with essential hypertension.

Authors:  J DE GRAEFF
Journal:  Acta Med Scand       Date:  1957-01-15

4.  THE MEASUREMENT OF EXTRACELLULAR FLUID IN MAN BY MEANS OF A CONSTANT INFUSION TECHNIQUE.

Authors:  I L Schwartz; D Schachter; N Freinkel
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

5.  Effect of nephrectomy and splanchnicectomy on plasma disappearance of labeled insulin in the rabbit.

Authors:  D L PALMER; R E BOLINGER
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

6.  Role of the kidney in the disposal of radioiodinated and nonradioiodinated insulin in dogs.

Authors:  D S Zaharko; L V Beck; R Blankenbaker
Journal:  Diabetes       Date:  1966-09       Impact factor: 9.461

7.  Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man.

Authors:  E A Rasio; C L Hampers; J S Soeldner; G F Cahill
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

8.  Insulin delivery rate into plasma in normal and diabetic subjects.

Authors:  M P Stern; J W Farquhar; A Silvers; G M Reaven
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

9.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

10.  Bilirubin turnover studies in normal and pathologic states using bilirubin-14C.

Authors:  V Barrett; P D Berk; M Menken; N I Berlin
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

View more
  11 in total

Review 1.  Urinary insulin levels in health and disease--a concise review.

Authors:  F Aun; M M Meguid; J S Soeldner; N A Stolf
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

2.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.

Authors:  David Czock; Frieder Keller; Hanna M Seidling
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  Effect of nephrectomy on the rate and pattern of the disappearance of exogenous gastrin in dogs.

Authors:  B G Clendinnen; D D Reeder; E N Brandt; J C Thompson
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

5.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Metabolic clearance rate of radioiodinated human calcitonin in man.

Authors:  R Ardaillou; P Sizonenko; A Meyrier; G Vallée; C Beaugas
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

7.  Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.

Authors:  R Navalesi; A Pilo; E Ferrannini
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

8.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  A model of the kinetics of insulin in man.

Authors:  R S Sherwin; K J Kramer; J D Tobin; P A Insel; J E Liljenquist; M Berman; R Andres
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1.

Authors:  Jale Yuzugulen; Julie A Douthwaite; Elizabeth G Wood; Inmaculada C Villar; Nimesh S A Patel; James Jegard; Hubert Gaertner; Irène Rossitto-Borlat; Keith Rose; Oliver Hartley; Pedro R Cutillas; Amrita Ahluwalia; Roger Corder
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.